Lite Strategy, Inc. (LITS): Dividends Paid
$0
Year ended 2025-06-30
| Period ended | Dividends Paid | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | $0 | -100.0% | 2025-09-26, From 2024-07-01 |
| 2024-06-30 | $11.66M | n/a | 2025-09-26, From 2023-07-01 |
| 2023-06-30 | $0 | n/a | 2024-09-19, From 2022-07-01 |
Dividends Paid at similar companies
| Company | Year ended | Dividends Paid | Change YoY |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | 2025-06-30 | $0 | -100.0% |
| Abbott Laboratories (ABT) | 2025-12-31 | $4.12B | +7.3% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $5.04B | +3.7% |
| Eli Lilly & Co (LLY) | 2025-12-31 | $5.38B | +15.0% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $8.18B | +4.3% |
| Lifevantage Corp (LFVN) | 2026-06-30 | $2.34M | +13.4% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $370.30M | n/a |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $43.12M | +1.1% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $1.16M | -28.8% |
Compare LITS, ABT, BMY, LLY side by side · Screen every company in Pharmaceutical Preparations ↗